Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple MyelomaGuillemette Fouquet, Xavier Leleu, Mathieu Wémeau et al.|Clinical Cancer Research|2014Cited by 74
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trialEileen M. Boyle, Xavier Leleu, Marie‐Odile Petillon et al.|British Journal of Haematology|2019Cited by 23
Prognostic Of IgD Myeloma In The Era Of Novel AgentsLuca Inchiappa, Xavier Leleu, Charles Herbaux et al.|Blood|2013Cited by 0
Impact Of Initial FGD-PET CT and Serum Free Light Chain On Transformation Of Solitary Plasmacytoma To MMGuillemette Fouquet, Xavier Leleu, Stéphanie Guidez et al.|Blood|2013Cited by 0
Safety Profile Of Bortezomib Impacts Survival Of Cardiac AL AmyloidosisZoé Van de Wyngaert, Xavier Leleu, Greg Vanoutryve et al.|Blood|2013Cited by 0